Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD)

Stopped This clinical trial was not approved by the regulatory entities. It was reviewed and a new trial was re-submitted.

Conditions

• Obsessive-Compulsive Disorder

Interventions

• DRUG: Pramipexole
• DRUG: Risperidone

Sponsor

Clinical Academic Center (2CA-Braga)

Collaborators

• [object Object]